Navigation Links
New CyberKnife Technologies Demonstrate Dramatic Reduction in Treatment Times
Date:8/5/2008

First Patients Treated Using Next Generation CyberKnife System at Oklahoma

CyberKnife Center

SUNNYVALE, Calif., Aug. 5 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that the first patients were treated using the next generation CyberKnife(R) Robotic Radiosurgery System that was recently installed at the Oklahoma CyberKnife, LLC in Tulsa, OK. The next generation CyberKnife System, which features new technologies and system upgrades announced at the 2007 American Society for Therapeutic Radiology and Oncology Annual Meeting, is capable of delivering state-of-the-art radiosurgery with significantly reduced treatment planning and delivery times.

Treatment results on the Oklahoma CyberKnife, LLC's first day were ground-breaking. While treatment times will vary based upon case complexity and type of cancer, the first patient treated for an intracranial lesion was completed in only 16 minutes. The next patient, treated for non-small cell lung cancer, required only 27 minutes of treatment time.

Incorporating all of the newest enhancements, the next generation CyberKnife System achieved a considerable reduction in treatment times. Using the latest advancement in treatment planning, Sequential Optimization enabled treatment plans to be developed in as little as 15 minutes. With the new 800 monitor unit/minute linear accelerator treatment times were reduced with a 30 percent faster rate of dose delivery as compared to previous systems. Further, the recently launched Iris(TM) Variable Aperture Collimator enabled very conformal, multi-collimator treatments to be rapidly delivered to even the most complex targets. And with the
'/>"/>

SOURCE Accuray Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. M. D. Anderson Cancer Center to Lead Study of Surgery vs. CyberKnife(R) Radiosurgery for Operable Lung Cancer Patients
2. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
3. King Pharmaceuticals and Palatin Technologies Delay Immediate Plans for Phase 3 Clinical Program With Bremelanotide for Erectile Dysfunction
4. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
5. Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study
6. New Clinical Studies Confirm Mauna Kea Technologies Cellvizio(R) GI in Range of Procedures
7. Palatin Technologies, Inc. Reports Initiation of Human Trials for the Treatment of Congestive Heart Failure
8. Emisphere Technologies, Inc. Announces 2007 Third Quarter Financial Results
9. Senesco Technologies Initiates Preclinical Studies for Cancer Target
10. ASEAN News: Epeius Biotechnologies Gains Commercial Approval for Rexin-G(R), a Tumor-Targeted Gene-Based Medicine for Metastatic Cancer
11. Epeius Biotechnologies Applauds the Belated Scholarship of Their Academic Contemporaries in 2007, As Targeted Gene Therapy Comes of Age in Clinical Medicine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2008)...O, Aug. 18 /- The next time you consi...ff, it might be worth counting sheep,instead. A se...er in San,Diego, Calif. has found evidence that ta...k of skin cancer., Daniel F. Kripke, M.D.,s artic...eeping pills and cancer, has just been published i...
(Date:8/18/2008)...iates Clinical Trials Phase of Test Development Pr...-FirstCall/ -- Beckman,Coulter, Inc. (NYSE: BEC )...y out its U.S. royalty obligation to Nephromics LL... women,s health. The license is for tests,related ...f preeclampsia, a,leading cause of maternal death....
(Date:8/17/2008)...Australia, Aug. 17 /Xinhua-...ed that the first pivotal Phase 3,clinical trial o...has,completed enrolment., The first efficacy data... the first half of 2009. The trial commenced its d...ruitment target of 250 subjects in June,2008 and c...
(Date:8/14/2008)...N, N.J., Aug. 14 /- Pharmas...aceutical company committed to,discovering, develo...l,infections, reported unaudited financial results... Pharmasset reported a net loss attributable to,co...share of $0.69 for the,quarter ended June 30, 2008...
Breaking Medicine Technology:Prescription Sleeping Pill Use Tied to Cancer 2Beckman Coulter Buys Out Royalty Obligation for Preeclampsia Markers 2Beckman Coulter Buys Out Royalty Obligation for Preeclampsia Markers 3Bronchitol Phase 3 Cystic Fibrosis Trial Completes Recruitment 2Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 2Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 3Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 4Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 5Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 6Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 7Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 8Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 9Targeted Genetics Announces Positive Phase 1 2 tgAAC94 Data Presented at Annual European Congress of Rheumatology 2399 1Targeted Genetics Announces Positive Phase 1 2 tgAAC94 Data Presented at Annual European Congress of Rheumatology 2399 2Targeted Genetics Announces Positive Phase 1 2 tgAAC94 Data Presented at Annual European Congress of Rheumatology 2399 3U S District Court Finds Arthrex Guilty of Willfully Infringing Smith 26 Nephew Endoscopy Patent 21638 1U S District Court Finds Arthrex Guilty of Willfully Infringing Smith 26 Nephew Endoscopy Patent 21638 2U S District Court Finds Arthrex Guilty of Willfully Infringing Smith 26 Nephew Endoscopy Patent 21638 3Pharmaxis Long Term Safety Study of Bronchitol Completes 2398 1Pharmaxis Long Term Safety Study of Bronchitol Completes 2398 2Helix BioPharma product development update quarterly highlights and financial results for fiscal Q3 2008 5946 1Helix BioPharma product development update quarterly highlights and financial results for fiscal Q3 2008 5946 2Helix BioPharma product development update quarterly highlights and financial results for fiscal Q3 2008 5946 3Helix BioPharma product development update quarterly highlights and financial results for fiscal Q3 2008 5946 4Helix BioPharma product development update quarterly highlights and financial results for fiscal Q3 2008 5946 5Helix BioPharma product development update quarterly highlights and financial results for fiscal Q3 2008 5946 6Helix BioPharma product development update quarterly highlights and financial results for fiscal Q3 2008 5946 7Helix BioPharma product development update quarterly highlights and financial results for fiscal Q3 2008 5946 8Helix BioPharma product development update quarterly highlights and financial results for fiscal Q3 2008 5946 9Helix BioPharma product development update quarterly highlights and financial results for fiscal Q3 2008 5946 10Helix BioPharma product development update quarterly highlights and financial results for fiscal Q3 2008 5946 11Helix BioPharma product development update quarterly highlights and financial results for fiscal Q3 2008 5946 12Helix BioPharma product development update quarterly highlights and financial results for fiscal Q3 2008 5946 13Helix BioPharma product development update quarterly highlights and financial results for fiscal Q3 2008 5946 14Helix BioPharma product development update quarterly highlights and financial results for fiscal Q3 2008 5946 15
...TADT, Germany, June 4, 2007 – Data presented...inical Oncology,(ASCO) meeting in Chicago show tha...rsquo;s oral 5-fluorouracil (5-FU) therapy UFT,(te... an excellent,response rate in the first-line trea... the SCOUT study (Study of CPT-11 with Oxaliplatin...
...TS, NJ – June 4, 2007 – Genta,Incorpor...results,from a Phase 2 clinical trial of its marke...n), plus rituximab (Rituxan®;,Genentech/IDEC) ...ractory non-Hodgkin’s lymphoma (NHL). The da...rican Society of Clinical,Oncology (ASCO) in Chica...
Other Medicine Technology:Merck at ASCO 2007: New Data Demonstrate the Value of UFT as an,Important Treatment Option for Patients With Metastatic Colorectal,Cancer 2Merck at ASCO 2007: New Data Demonstrate the Value of UFT as an,Important Treatment Option for Patients With Metastatic Colorectal,Cancer 3Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 2Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 3Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 4Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 5
(Date:8/20/2008)...r-old Contestant Wins Trip to Little League Baseba... The National Spit Tobacco Education,Program (NSTE...st today,and encouraged young baseball players to...ddiction and the health risks of using tobacco pro...year,s slogan contest winner is,Joe Reck, a nine-y...
(Date:8/20/2008)...cently enacted Medicare Improvement Law immediatel...re Advantage insurance companies .../PRNewswire/ -- When the House and Senate,overrode...gislation,protecting Medicare beneficiaries, they ...e Advantage plans during one of the busiest months...
(Date:8/20/2008)...T CREEK, Calif., Aug. 20 /PRNewswire-FirstCall/ --... reported preliminary income from,continuing opera...f $27.5,million, or $0.76 per diluted share, inclu...er diluted share, related to provisions for store,... a 6.8 percent increase,compared with income from ...
(Date:8/20/2008)...FIELD, Mich., Aug. 20 /PRNewswire/ -- WXYZ- TV/Cha...llness Promotion will give thousands of,Detroit me...ALTHY LIVING,FOR KIDS" program. This year the prog....m. to 5 p.m. at the Charles H. Wright Museum of A...77, "Healthy Living for Kids",has provided free im...
Breaking Medicine News(10 mins):Health News:Slogan Contest Educates Young Baseball Players About the Dangers of Tobacco Use 2Health News:Medicare Advantage Plans Struggle to Comply With New Federal Law 2Health News:Longs Drug Stores Corporation Reports Second Quarter Results 2Health News:Longs Drug Stores Corporation Reports Second Quarter Results 3Health News:Longs Drug Stores Corporation Reports Second Quarter Results 4Health News:Longs Drug Stores Corporation Reports Second Quarter Results 5Health News:Longs Drug Stores Corporation Reports Second Quarter Results 6Health News:Longs Drug Stores Corporation Reports Second Quarter Results 7Health News:Longs Drug Stores Corporation Reports Second Quarter Results 8Health News:Longs Drug Stores Corporation Reports Second Quarter Results 9Health News:Longs Drug Stores Corporation Reports Second Quarter Results 10Health News:Longs Drug Stores Corporation Reports Second Quarter Results 11Health News:Longs Drug Stores Corporation Reports Second Quarter Results 12Health News:Longs Drug Stores Corporation Reports Second Quarter Results 13Health News:WXYZ-TV/Channel 7 is 'On Your Side' With Healthy Living For Kids; Free Immunizations for Children on Sunday, August 24 at Charles H. Wright Museum of African American History 2Health News:WXYZ-TV/Channel 7 is 'On Your Side' With Healthy Living For Kids; Free Immunizations for Children on Sunday, August 24 at Charles H. Wright Museum of African American History 3
...shed yesterday looks into support props for care g... elucidates the plight of most relatives // and ca...ften the rehabilitation and restoration of confide... realms of hospital in –patient care. It is the v...
...sions for breast cancer fell by a third between 19...ncy for Healthcare Research and Quality. The decli...cilities for breast cancer surgeries, plus the gro...ns such as lumpectomies, which are typically perfo...
...survivors will be able to do away with invasive br...ch involving stem cells //extracted from their own... who are investigating the potential these cells m.... In animal models, the researchers hope to prove...
...hyam Sarda, a prime accused in the expired blood t...nior police official.// "We have arrested Ghanshy...uced in court," said Gyanwant Singh, deputy commis... department). Ghanshyam's brother, Govind Sarda,...
Other Medicine News:Health News:Breast reconstruction may be possible with fat stem cells 2
.../Cuff combines the therapeutic benefits of control...ing, and cold to minimize pain. The cuff is anatom...ing maximum cryotherapy. The Elbow Cryo/Cuff is av...c size.,All Cryo/Cuffs can be ordered as a single ...
...; ROM Elbow Orthosis features aluminum cuffs that ...r joint alignment, unique slot/screw adjustment me...l adjustments to cuff position. Cuffs are configur...with contractures.,The hinge can be locked in any...
...CTION Elbow Wrap replaces messy taping and bulky e...s experiencing epicondylitis. Preferred by doctors...y fit. Two overlay straps allow you to apply force...lds the Elbow Wrap comfortably in place. Available...
The Bledsoe Original Arm Brace is designed to handle post-op elbow arthroscopy, severe elbow strains and ligament trauma. The Bledsoe Extender Arm Brace should be used when limited R.O.M. or locked c
Medicine Products: